4 Results (Page 1 of 1)
South Korea Free Sample Markets Research Reports
South Korea Cancer Immunotherapy Market Analysis Sample Report
South Korean cancer immunotherapy market is expected to grow from $1.64 Bn in 2022 to $3.06 Bn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The increase in the ageing population and the demand for new and innovative treatment options in South Korea have led to the growth of the market. The South Korean cancer immunotherapy market is segmented by type, application, and end user. Selecxine, Panolos Bioscience, and Bayer are the major players in the South Korean cancer immunotherapy market.
South Korea Telemedicine Market Analysis Sample Report
This report presents a strategic analysis of the South Korea Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Telemedicine Market, offering unmatched value, accuracy and expert insights.
South Korea Digital Health Market Analysis Sample Report
The South Korea digital health market is projected to witness growth from $3.08 Bn in 2022 to $12.9 Bn in 2030 with a CAGR of 19.6% for the year 2022-2030. South Korea is a digital pioneer with some of the fastest internet speeds in the world. Telehealth, mhealth, and health analytics are major types of digital health services in South Korea.
South Korea Diabetes Devices Market Analysis Sample Report
South Korea's diabetes devices market is expected to witness growth from $332 Mn in 2022 to $624 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The South Korean elderly population is predicted to raise the number of diabetes diagnoses, which will increase demand for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Dongmun, Sejung Medical Industry, Medyssey, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.